Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5

Human recombinant lipocortins (LCT) 1 and 5 have been expressed in a yeast secretion vector and purified by ion exchange chromatography. The action of the proteins has been investigated in two models of experimental acute inflammation in the rat: carrageenin induced paw oedema and zymosan induced pl...

Full description

Saved in:
Bibliographic Details
Main Authors: C. Becherucci, M. Perretti, E. Solito, C. L. Galeotti, L. Parente
Format: Article
Language:English
Published: Wiley 1993-01-01
Series:Mediators of Inflammation
Online Access:http://dx.doi.org/10.1155/S0962935193000158
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850216610387722240
author C. Becherucci
M. Perretti
E. Solito
C. L. Galeotti
L. Parente
author_facet C. Becherucci
M. Perretti
E. Solito
C. L. Galeotti
L. Parente
author_sort C. Becherucci
collection DOAJ
description Human recombinant lipocortins (LCT) 1 and 5 have been expressed in a yeast secretion vector and purified by ion exchange chromatography. The action of the proteins has been investigated in two models of experimental acute inflammation in the rat: carrageenin induced paw oedema and zymosan induced pleurisy. The effects of the proteins on PGE2 release in vitro by rat macrophages stimulated with zymosan and on rat neutrophil chemotaxis induced by FMLP have also been assessed. LCT-1 significantly inhibited both paw swelling in carrageenin oedema and leukocyte migration in zymosan pleurisy. Moreover it showed a dose dependent, inhibitory effect on PGE2 release. Neutrophil chemotaxis was only weakly affected by LCT-1. Conversely LCT-5 did not reduce carrageenin oedema and slightly inhibited PGE2 release, but showed profound, dose dependent inhibitory activity on leukocyte migration in zymosan pleurisy and on neutrophil chemotaxis. These data suggest that LCT-1 acts mainly by interfering with arachidonic acid metabolism via the inhibition of phospholipase A2. The anti-inflammatory activity of LCT-5, at variance with LCT-1, may be due to a direct effect on cell motility in addition to the interference with arachidonic acid metabolism.
format Article
id doaj-art-36263cd8e75942c59ca82c1621cd7fcd
institution OA Journals
issn 0962-9351
1466-1861
language English
publishDate 1993-01-01
publisher Wiley
record_format Article
series Mediators of Inflammation
spelling doaj-art-36263cd8e75942c59ca82c1621cd7fcd2025-08-20T02:08:15ZengWileyMediators of Inflammation0962-93511466-18611993-01-012210911310.1155/S0962935193000158Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5C. Becherucci0M. Perretti1E. Solito2C. L. Galeotti3L. Parente4Department of Pharmacology, Immunobiological Research Institute Siena, Siena 53100, ItalyDepartment of Biochemical Pharmacology, The William Harvey Research Institute, St. Bartholomew's Hospital Medical School, Charterhouse Square, London EC1M 6BQ, UKDepartment of Pharmacology, Immunobiological Research Institute Siena, Siena 53100, ItalyDepartment of Molecular Biology, Immunobiological Research Institute Siena, Siena 53100, ItalyDepartment of Pharmacology, Immunobiological Research Institute Siena, Siena 53100, ItalyHuman recombinant lipocortins (LCT) 1 and 5 have been expressed in a yeast secretion vector and purified by ion exchange chromatography. The action of the proteins has been investigated in two models of experimental acute inflammation in the rat: carrageenin induced paw oedema and zymosan induced pleurisy. The effects of the proteins on PGE2 release in vitro by rat macrophages stimulated with zymosan and on rat neutrophil chemotaxis induced by FMLP have also been assessed. LCT-1 significantly inhibited both paw swelling in carrageenin oedema and leukocyte migration in zymosan pleurisy. Moreover it showed a dose dependent, inhibitory effect on PGE2 release. Neutrophil chemotaxis was only weakly affected by LCT-1. Conversely LCT-5 did not reduce carrageenin oedema and slightly inhibited PGE2 release, but showed profound, dose dependent inhibitory activity on leukocyte migration in zymosan pleurisy and on neutrophil chemotaxis. These data suggest that LCT-1 acts mainly by interfering with arachidonic acid metabolism via the inhibition of phospholipase A2. The anti-inflammatory activity of LCT-5, at variance with LCT-1, may be due to a direct effect on cell motility in addition to the interference with arachidonic acid metabolism.http://dx.doi.org/10.1155/S0962935193000158
spellingShingle C. Becherucci
M. Perretti
E. Solito
C. L. Galeotti
L. Parente
Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5
Mediators of Inflammation
title Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5
title_full Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5
title_fullStr Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5
title_full_unstemmed Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5
title_short Conceivable difference in the anti-inflammatory mechanisms of lipocortins 1 and 5
title_sort conceivable difference in the anti inflammatory mechanisms of lipocortins 1 and 5
url http://dx.doi.org/10.1155/S0962935193000158
work_keys_str_mv AT cbecherucci conceivabledifferenceintheantiinflammatorymechanismsoflipocortins1and5
AT mperretti conceivabledifferenceintheantiinflammatorymechanismsoflipocortins1and5
AT esolito conceivabledifferenceintheantiinflammatorymechanismsoflipocortins1and5
AT clgaleotti conceivabledifferenceintheantiinflammatorymechanismsoflipocortins1and5
AT lparente conceivabledifferenceintheantiinflammatorymechanismsoflipocortins1and5